Journal of Yeungnam Medical Science

Original article

Incidence and severity of medication-related osteonecrosis of the jaw in patients with osteoporosis using data from a Korean nationwide sample cohort in 2002 to 2019: a retrospective study: Su-Youn Ko, Tae-Yoon Hwang, Kiwook Baek, Chulyong Park; J Yeungnam Med Sci. 2024;41(1):39-44. Published online January 3, 2024; DOI: https://doi.org/10.12701/jyms.2023.01116

968 View
53 Download

Abstract PDF: Background
Medication-related osteonecrosis of the jaw (MRONJ) is a significant concern, particularly among patients taking bisphosphonates (BPs), denosumab, and selective estrogen receptor modulators (SERMs) for osteoporosis. Despite the known risks, large-scale cohort studies examining the incidence and severity of MRONJ are lacking. We aimed to ascertain the incidence and risk of MRONJ among these patients, whom we stratified by age groups, medication types, and duration of use.
Methods
We utilized data from the National Health Insurance Service’s sample cohort database, focusing on patients aged 40 years and above diagnosed with osteoporosis. The patients were divided into three groups: those prescribed BPs only, those prescribed SERMs only, and those prescribed both.
Results
The overall incidence rate of MRONJ was 0.17%. A significantly higher incidence rate was observed among those taking osteoporosis medications, particularly among females with a relative risk of 4.99 (95% confidence interval, 3.21–7.74). The SERM group also had an incidence rate comparable to that of the BP group. Severity was assessed based on the invasiveness of the treatment methods, with 71.3% undergoing invasive treatment in the medication group.
Conclusion
This study provides valuable insights into the incidence and severity of MRONJ among a large cohort of patients with osteoporosis. It underscores the need for comprehensive guidance on MRONJ risks across different medication groups and sets the stage for future research focusing on specific populations and treatment outcomes.

Case report

Transient osteoporosis of the hip with a femoral neck fracture during follow-up: a case report: Yusuke Tabata, Shuhei Matsui, Masabumi Miyamoto, Koichiro Omori, Yoichiro Tabata, Tokifumi Majima; J Yeungnam Med Sci. 2023;40(2):212-217. Published online September 26, 2022; DOI: https://doi.org/10.12701/jyms.2022.00479

2,154 View
59 Download
1 Web of Science
1 Crossref

We report a case of transient osteoporosis of the hip with a femoral neck fracture found during follow-up. A 53-year-old man presented with left hip pain without trauma. The pain did not improve after 2 weeks and he was brought to our hospital by ambulance. Magnetic resonance imaging (MRI) of the left hip joint showed diffuse edema in the bone marrow, which was identified by low signal intensity on T1-weighted images, high signal intensity on T2-weighted images, and increased signal intensity on short tau inversion recovery. This edema extended from the femoral head and neck to the intertrochanteric area. He was diagnosed with transient osteoporosis of the left hip. Rest gradually improved his pain; however, 3 weeks later, his left hip pain worsened without trauma. X-ray, computed tomography, and MRI results of the hip joint demonstrated a left femoral neck fracture, and osteosynthesis was performed. Differential diagnoses included avascular necrosis of the femoral head, infection, complex regional pain syndrome, rheumatoid arthritis, leukemia, and other cancers. Transient osteoporosis of the hip generally has a good prognosis with spontaneous remission within a few months to 1 year. However, a sufficient length of follow-up from condition onset to full recovery is necessary to avoid all probable complications such as fractures.

Citations

Citations to this article as recorded by

Hip effusion/synovitis influences results after multiple drilling core decompression for bone marrow edema syndrome of hip
Hua-zhang Xiong, Yan-li Peng, Yu-hong Deng, Ying Jin, Ming-hong Tu, Shu-hong Wu
BMC Surgery.2023;[Epub] CrossRef

Reviews

The Diagnosis and Treatment of Osteoporosis.: Jun sung Moon, Kyu Chang Won; Yeungnam Univ J Med. 2008;25(1):19-30. Published online June 30, 2008; DOI: https://doi.org/10.12701/yujm.2008.25.1.19

2,010 View
11 Download
12 Crossref

Abstract PDF

Osteoporosis, a disease characterized by low bone mass and microarchitectural deterioration of bone tissue leading to enhanced bone fragility and fracture risk, is a major public health problem. The diagnostic methods for osteoporosis include simple radiography, bone scan, DXA (Dual energy X-ray Absortiometry) and biochemical markers of bone turnover. Optimal treatment and prevention of osteoporosis require modification of risk factors, particularly smoking cessation, adequate physical activity, and attention to diet, in addition to pharmacologic intervention. The estrogens and raloxifene both prevent bone loss in postmenopausal women, and the estrogens probably also decrease the risk of first fracture. There is good evidence that raloxifene prevents further fractures in postmenopausal women who already have had fractures and some evidence that estrogen does as well. Bisphosphonate prevents bone loss and reduces fractures in healthy and osteoporotic postmenopausal women and in osteoporotic men as well. Risedronate is more potent and has fewer side effects than alendronate and reduces the incidence of fractures in osteoporotic women. Calcitonin increases bone mineral density in early postmenopausal women and men with idiopathic osteoporosis, and also reduces the risk of new fractures in osteoporotic women. All of the agents discussed above prevent bone resorption, whereas teriparatide and strontium increase bone formation and are effective in the treatment of osteoporotic women and men. New avenues for targeting osteoporosis will emerge as our knowledge of the regulatory mechanisms of bone remodeling increases, although issues of tissue specificity may remain to be addressed.

Citations

Citations to this article as recorded by

Effects of Gloiopeltis furcata Extract on Antioxidant Activity and Osteoblast Differentiation
Jeong Hyeon Kang, Kyung Im Jung, Mi Hwa Park, Geun Hye Oh, Mihyang Kim
Journal of the Korean Society of Food Science and Nutrition.2023; 52(5): 450. CrossRef
Effects of Herbal Medicines on Bone Mineral Density Score in Osteoporosis or Osteopenia: Study Protocol for a Systematic Review and Meta-Analysis
Su Min Hong, Eun Jung Lee
Journal of Korean Medicine Rehabilitation.2021; 31(2): 49. CrossRef
Effects of Joaguihwan (JGH, 左歸丸) Extract on Changes of Anti-oxidation, Anti-inflammatory in RAW 264.7 Cells and on Factors Related with Bone Metabolism in Skull Fractured Rat
Yu Chen Li, Min-seok Oh
Journal of Korean Medicine Rehabilitation.2016; 26(3): 31. CrossRef
The Effects of Long term Osteoporosis Management Education on BMD Level and Medication Compliance in Postmenopausal Women
Dong-Hee Kim, Young-Sil Bae, Sang-Hwa Lee
Journal of Korean Public Health Nursing.2014; 28(1): 102. CrossRef
Consumption of health functional food and dietary habits, nutrient intake and dietary quality of college students in Incheon
So Young Kim, Jeong Soon You, Kyung Ja Chang
Korean Journal of Nutrition.2013; 46(2): 166. CrossRef
The usefulness of MR subtraction technique in metastatic spinal cancer
J-H Cho, H-K Lee, B-J Han, J Lee, K-R Dong, W-K Chung, J-Y Bae
The Imaging Science Journal.2013; 61(5): 419. CrossRef
Correlations between the MR Diffusion-weighted Image (DWI) and the bone mineral density (BMD) as a function of the soft tissue thickness-focus on phantom and patient
Myung-Sam Kim, Jae-Hwan Cho, Hae-Kag Lee, Sang-Jeong Lee, Cheol-Soo Park, Kyung-Rae Dong, Yong-Soon Park, Woon-Kwan Chung, Jong-Woong Lee, Ho-Sung Kim, Eun-Hye Kim, Dae Cheol Kweon, Hwa-Yeon Yeo
Journal of the Korean Physical Society.2013; 62(4): 684. CrossRef
A study on quantitative analyses before and after injection of contrast medium in spine examinations performed by using diffusion weighted image
Jae-Hwan Cho, Hae-Kag Lee, Yong- Kyun Kim, Kyung-Rae Dong, Woon-Kwan Chung, Kyu-Ji Joo
Journal of the Korean Physical Society.2013; 62(4): 700. CrossRef
The Correlation Analysis of BMD in Proximal Femur and Spine with Dual Energy X-ray Absorptiometry
Man-Seok Han, Dong-Heon Cho
Journal of the Korea Society of Computer and Information.2012; 17(9): 165. CrossRef
Influence of Knowledge and Subjective Health Status on Health Promoting Behavior About Osteoporosis in Industrial Workers
Soon Yi Seo, Jung Soon Lee
Journal of muscle and joint health.2012; 19(3): 340. CrossRef
SNR and ADC Value Change before and after the injection of contrast medium during DWI test on metastatic spinal cancer patients
Eng-Chan Kim, Ki-Hong Kim, Cheol-Soo Park, Sun-Yeob Lee, Heung-Joon Yoo, Jae-Hwan Cho, Hyun-Cheol Jang, Bo-Hui Kim, Man-Seok Han
Journal of the Korean Society of Radiology.2011; 5(1): 37. CrossRef
Bone Mineral Density and Factors Affecting in Female College Students
Dong Sook Cho, Jeung Yun Lee
Korean Journal of Women Health Nursing.2008; 14(4): 297. CrossRef

Recent Advances in the Drug Therapy of Osteoporosis.: Hyoung Woo Lee; Yeungnam Univ J Med. 1999;16(2):155-168. Published online December 31, 1999; DOI: https://doi.org/10.12701/yujm.1999.16.2.155

1,413 View
1 Download

Abstract PDF: Osteoporosis is one of the most important public health problems facing the aging population. Drug therapy for osteoporosis can be divided operationally into two main categories: drugs that inhibit bone resorption, and thus reduce bone turnover, and those that stimulate bone formation, exerting an anabolic effect. Antiresorptive agents such as estrogens, calcitonin, and bisphosphonates are most effective in the prevention of osteoporosis. Formation-stimulating agents such as sodium fluoride or monofluorophosphate, parathyroid hormone fragments, and anabolic steroids are of potential value in the treatment of established osteoporosis, where bone mass s already low and benefit from antiresorptive drug is likelyto be small. Recently, raloxifene, a selective estrogen receptor modulator, has become available in various countries for clinical use in the treatment of involutional osteoporsis . This paper will review the use of these drugs in postmenopausal woman.

Original Article

Factors Affecting to Bone Mineral Density in Postmenopausal Women.: Seung Pil Jung, Keun Mi Lee, Suk Hwan Lee; Yeungnam Univ J Med. 1996;13(2):261-271. Published online December 31, 1996; DOI: https://doi.org/10.12701/yujm.1996.13.2.261

1,645 View
1 Download
3 Crossref

Abstract PDF

INTRODUCTION: Osteoporosis, the most common metabolic bone disorder, is a condition of reduced bone density and increased susceptibility to fractures. Osteoporosis is a major public health problem and a significant cause of morbidity in postmenopausal women. Therefore family physicians as primary care physicians are in a key position for preventing and treating this disorder. So we studied the factors affecting to bone mineral density in postmenopausal women. MATERIALS AND METHODS: A total of 136 spontaneous postmenopausal women were participated in the study. They have measured spinal bone mineral density by dual energy x-ray absorptiometry from January 1992 to June 1995 at Yeungnam University Hospital. Age, height, weight, age at menarche and menopause, number of child and breast feeding child, history of oral pill ingestion, family history of osteoporosis, amount of milk and coffee ingestion, consumption of tobacco and alcohol and physical activity were assessed by qustionnaire and medical records. RESULTS: physical activity and weight were significant contributors. Physical activity is most the largest contributor. CONCLUSIONS: Among factors affecting to BMD in postmenopausal women, physical activity and weight were more important factors. Therefore continuous physical activity is significant factor to prevent osteoporosis in postmenopausal women.

Citations

Citations to this article as recorded by

The Bone Mineral Density Impact Factors of Adult Women before the Menopause - based on the National Health and Nutrition Examination Survey -
Kyung-Hee Kim, Jung-Hee Lee, Jin-Dong Yeo
Journal of the Korean Society of Radiology.2015; 9(3): 147. CrossRef
The association of dietary quality and food group intake patterns with bone health status among Korean postmenopausal women: a study using the 2010 Korean National Health and Nutrition Examination Survey Data
Gyeongah Go, Zuunnast Tserendejid, Youngsook Lim, Soyeon Jung, Younghee Min, Haeryun Park
Nutrition Research and Practice.2014; 8(6): 662. CrossRef
Association of Bone Mineral Density and Blood Pressure, Calcium Intake among Adult Women in Seoul · Kyunggi Area - Based on 2011 KNHANES -
Jae Ok Koo
Korean Journal of Community Nutrition.2013; 18(3): 269. CrossRef

First
Prev
Page of 1
Next
Last

Search